Sector Monte Rosa Therapeutics, Inc.

Aandelen

GLUE

US61225M1027

Biotechnologie & Medisch Onderzoek

Beurs gesloten - Nasdaq 22:00:00 13-07-2026 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
21,98 USD -4,60% Intraday-grafiek van Monte Rosa Therapeutics, Inc. -5,46% +40,18%
Belangrijkste concurrenten
Verschil (%) Varia. 5d. Evolutie 1 maand Evolutie 3 maanden Var. 1 jan Varia. 1j. Varia. 3j. Varia. 5j. Varia. 10j. Kap.($)
-4,60%-5,46%+20,54%+25,24%+40,18%+325,97%+206,56%+18,24% - 1,86 mld.
+0,44%+1,41%+20,05%+13,85%+9,45%+4,36%+10,81%-12,02%+250,57% 50,61 mld.
-1,57%-3,18%+19,55%+34,96%+130,95%+383,82%+593,37%+480,10% - 39,11 mld.
-0,14%+0,77%+14,38%+20,68%-7,92%+27,49%-5,50%-16,86%+192,08% 34,64 mld.
+1,76%-1,78%+14,93%-0,55%+0,05%+21,44%+53,38%-7,99%+921,71% 33,79 mld.
-0,06%-0,45%+1,21%-5,81%+1,58%+2,94%+28,70%-19,02%+149,43% 26,89 mld.
-1,93%-1,01%+21,63% - - - - - - 16,47 mld.
-1,49%-6,18%+13,45%+5,78%-5,60%+63,89%+120,53%+188,92% - 15,14 mld.
+0,78%+1,16%+8,46%+7,09%+11,38%+14,69%+17,32%-31,76%+104,41% 13,85 mld.
-0,97%-2,83%+13,63%+50,49%-8,85%+10,35%-33,29%-20,91%+132,73% 12,72 mld.
-2,28%-6,83%+41,21%+14,60%-0,25%+1.589,17%+646,89%+314,14%+2.971,61% 11,8 mld.
-1,57%-0,73%+22,53%+28,83%+15,17%+44,13%+9,84%-40,03%+170,42% 11,07 mld.
+0,08%+0,62%+32,15%+24,04%+21,34%+31,81%-15,49%-37,05%+149,66% 11,12 mld.
-3,95%-7,86%+16,96%+21,64%-5,28%-1,67% - - - 10,04 mld.
+0,13%+0,24%+51,50%+54,28%+77,29%+250,87% - - - 10,03 mld.
-7,50%-3,80%+28,07%+24,70%+41,88%+148,20%+395,29%+126,51% - 9,08 mld.
-2,58%-31,77%-22,55%-24,28%-28,26%+35,99%+33,03%+56,08%+129,94% 9,38 mld.
-3,21%+0,34%+18,00%-0,77%+6,72%+522,40%+1.476,74%+11,19% - 8,77 mld.
-0,13%-5,93%+17,14%+53,69%+85,38%+71,30%+72,84%+112,23%+8,38% 8,65 mld.
-0,17%+5,85%+11,82%-1,12%-12,46%-18,20%-19,48%-21,24%+62,06% 8,57 mld.
Gemiddelde -1,45%-3,34%+18,23%+18,28%+19,62%+185,73%+211,27%+64,74%+436,92% 17,18 mld.
Gewogen gemiddelde per kap. -0,74%-2,16%+17,27%+16,66%+22,42%+145,88%+172,77%+79,48%+420,80%
Biotechnologie & Medisch Onderzoek - Andere
  1. Beurs
  2. Aandelen
  3. Koers GLUE
  4. Sector Monte Rosa Therapeutics, Inc.